The FDA has issued a complete response letter to the biologics license application seeking the approval of tabelecleucel for ...

Failed to fetch dynamically imported module: https://sg.finance.yahoo.com/assets/_app/immutable/nodes/98.Bghnd5-7.js ...

Shares of Atara Biotherapeutics, Inc. (NASDAQ:ATRA) tumbled 51% after the company disclosed receiving a Complete Response ...

Older people who regularly drink green tea have fewer brain lesions are characteristic of dementia than those who do not ...

As per NPJ - Science of Food, participants who drank 600 ml of green tea as compared to a consumption level of 200 ml had 3% less brain damage.

Research led by the Kanazawa University Graduate School of Medical Sciences has reported a significant connection between ...

Cases of dementia in the United States are expected to rise to 1 million per year by 2060, with Black individuals, women and ...

A new study finds that dementia cases will increase at a much higher rate than expected, with lifetime risk rising to 42 ...

Entering 2025 having demonstrated rapid translation of genetic insights to positive clinical data; advancing clinically validated and multi-modal pipeline with the potential to treat well over 100 mil ...

Entering 2025 having demonstrated rapid translation of genetic insights to positive clinical data; advancing clinically validated and multi-modal ...

This study aimed to investigate the association between the interleukin-1 beta (IL-1β) gene polymorphism (rs2853550) and the risk of rheumatoid arthritis (RA) in a sample of the Iraqi population. The ...

ApoE is a key genetic risk factor for certain forms of Alzheimer's disease, whose 3 variants (E2, E3, E4) influence the progression of the disease in different ways. People carrying the E4 allele have ...